bioAffinity Technologies (BIAF) Non Operating Income (2022 - 2026)
bioAffinity Technologies (BIAF) posted quarterly Non Operating Income of -$13634.0 for Q1 2026, up 44.54% year-over-year from -$9432.8 in Q1 2025, and down 609.11% quarter-over-quarter from $2678.0 in Q4 2025.
bioAffinity Technologies (BIAF) Non Operating Income (2022 - 2026) Analysis & Trends
bioAffinity Technologies (BIAF) has reported Non Operating Income for 5 consecutive years, with -$13634.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Non Operating Income rose 44.54% year-over-year to -$13634.0; the TTM figure through Mar 2026 stood at -$4.3 million (down 4855.97% YoY), while the FY2025 annual figure was -$4.3 million, down 5644.49% from the prior year.
- Non Operating Income fell to -$13634.0 in Q1 2026 per BIAF's latest filing, from $2678.0 in the prior quarter.
- Across five years, Non Operating Income topped out at $42764.0 in Q2 2023 and bottomed at -$2.8 million in Q3 2025.
- Historically, Non Operating Income has averaged -$390812.5 across 5 years, with a median of -$18703.0 in 2024.
- On a YoY basis, Non Operating Income climbed as much as 113.16% in 2025 and fell as far as 11183.35% in 2025.
- bioAffinity Technologies' Non Operating Income stood at -$1.1 million in 2022, then surged by 97.52% to -$28466.0 in 2023, then climbed by 28.53% to -$20344.0 in 2024, then jumped by 113.16% to $2678.0 in 2025, then plunged by 609.11% to -$13634.0 in 2026.
- Business Quant data shows BIAF's Non Operating Income at -$13634.0 in Q1 2026, $2678.0 in Q4 2025, and -$2.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | - |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | - |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | - |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | - |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | - |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | - |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | 15.00 Mn |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | - |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | - |
| 10 | bioAffinity Technologies | 1.78 Mn | -649,139.45 | - | -31,218.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -31,218.00 |
| Mar 31, 2026 | -13,634.00 |
| Dec 31, 2025 | 2,678.00 |
| Sep 30, 2025 | -2.76 Mn |
| Jun 30, 2025 | -1.52 Mn |
| Mar 31, 2025 | -24,583.00 |
| Dec 31, 2024 | -20,344.00 |
| Sep 30, 2024 | -24,417.00 |
| Jun 30, 2024 | -17,062.00 |
| Mar 31, 2024 | -12,913.00 |
| Dec 31, 2023 | -28,466.00 |
| Sep 30, 2023 | 5,914.00 |
| Jun 30, 2023 | 42,764.00 |
| Mar 31, 2023 | 36,999.00 |
| Mar 31, 2022 | -1.15 Mn |